Analysis of Factors That May Affect the Effect of Atropine 0.01% on Myopia Control

Children respond differently to atropine treatment, and predicting patient factors associated with better myopia control is important. Therefore, we aimed to evaluate factors related to myopia progression in Chinese children treated with atropine 0.01%. This retrospective study included 133 children...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaoyu Zhang (Author), Yuliang Wang (Author), Xingtao Zhou (Author), Xiaomei Qu (Author)
Format: Book
Published: Frontiers Media S.A., 2020-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_1ceb8a538c7a4efda2ed29e8d74cb72b
042 |a dc 
100 1 0 |a Xiaoyu Zhang  |e author 
700 1 0 |a Xiaoyu Zhang  |e author 
700 1 0 |a Xiaoyu Zhang  |e author 
700 1 0 |a Yuliang Wang  |e author 
700 1 0 |a Yuliang Wang  |e author 
700 1 0 |a Yuliang Wang  |e author 
700 1 0 |a Xingtao Zhou  |e author 
700 1 0 |a Xingtao Zhou  |e author 
700 1 0 |a Xingtao Zhou  |e author 
700 1 0 |a Xiaomei Qu  |e author 
700 1 0 |a Xiaomei Qu  |e author 
700 1 0 |a Xiaomei Qu  |e author 
245 0 0 |a Analysis of Factors That May Affect the Effect of Atropine 0.01% on Myopia Control 
260 |b Frontiers Media S.A.,   |c 2020-09-01T00:00:00Z. 
500 |a 1663-9812 
500 |a 10.3389/fphar.2020.01081 
520 |a Children respond differently to atropine treatment, and predicting patient factors associated with better myopia control is important. Therefore, we aimed to evaluate factors related to myopia progression in Chinese children treated with atropine 0.01%. This retrospective study included 133 children who were administered atropine 0.01% eyedrops every night for 1 year. Enrolled children were examined at follow-up visits at 3 and 6 months, and 1 year. The primary outcome was clinically significant myopia progression (over a -0.75 diopter (D) increase in spherical equivalent (SE)). Multivariate logistic analysis was used to identify predictive factors for myopia progression. The mean baseline SE was -3.92 ± 2.76D, and the average increase in SE and axial length at 1 year from baseline were -0.55 ± 0.57D and 0.43 ± 0.52 mm, respectively. The risk of myopia progression significantly increased in children whose mothers had moderate myopia of less than -6D compared to that in children whose mothers had no history of myopia (odd ratio [OR] = 2.76, 95% confidence interval [CI]: 1.06 to 7.19, P = 0.0382). Birth by cesarean section was also a risk factor for myopia progression (odd ratio [OR] = 2.35, 95% CI: 1.30 to 4.27, P = 0.0048). The correlation between SE and treatment efficiency was linear, and the risk of myopia progression significantly decreased with increasing SE. Atropine 0.01% controlled myopia more effectively in children with higher myopia, who were delivered naturally, and whose mothers had no genetic background of myopia. 
546 |a EN 
690 |a myopia 
690 |a atropine 
690 |a retrospective study 
690 |a Chinese children 
690 |a myopia progression 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pharmacology, Vol 11 (2020) 
787 0 |n https://www.frontiersin.org/article/10.3389/fphar.2020.01081/full 
787 0 |n https://doaj.org/toc/1663-9812 
856 4 1 |u https://doaj.org/article/1ceb8a538c7a4efda2ed29e8d74cb72b  |z Connect to this object online.